Evidence map›Paper›PMID 23392373›Full record

Trial reportPediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies2013

Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study.

An N Massaro, Andreas Jeromin, Nadja Kadom, Gilbert Vezina, Ronald L Hayes, Kevin K W Wang, Jackson Streeter, Michael V Johnston

Abstract readClinical Trial
In one paragraph

Trial report in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
11.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Observational
  8. Review
  9. Observational
  10. Article
  11. Observational
  12. Article
  13. Bedside and laboratory neuromonitoring in neonatal encephalopathy.Seminars in fetal & neonatal medicine · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

An N MassaroDepartment of Neonatology, Children's National Medical Center, WA, USA. anguyenm@cnmc.org
Andreas Jeromin
Nadja Kadom
Gilbert Vezina
Ronald L Hayes
Kevin K W Wang
Jackson Streeter
Michael V Johnston
Banyan Biomarkers (United States) · USChildren's National · USKennedy Krieger Institute · US

Funding

ZAP-70 EXPRESSION, CD38 EXPRESSION AND PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIAM01RR020359 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI MIRZA, NAZRAT · 2005 to 2010
$13.8M
Pediatric Clinical Research Scholar Program - WashingtonK12RR017613 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI LUBAN, NAOMI L · 2002 to 2007
$4.8M
Clinical and Translational Science Institute at Children's NationalKL2RR031987 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2010 to 2011
$425k
NCRR NIH HHS 1KL2RR031987-01NCRR NIH HHS 5K12RR17613-05NCRR NIH HHS K12 RR017613NCRR NIH HHS KL2 RR031987NCRR NIH HHS M01 RR020359
6 · The paper itself

Abstract

objectivesTo determine if candidate biomarkers, ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein, are elevated in neonates with hypoxic ischemic encephalopathy who die or have severe MRI injury compared with surviving infants with minimal or no injury on brain MRI.

designProspective observational study.

settingLevel IIIC outborn neonatal ICU in a free-standing children's hospital. PATIENTS: Term newborns with moderate-to-severe hypoxic ischemic encephalopathy referred for therapeutic hypothermia

interventionsSerum specimens were collected at 0, 12, 24, and 72 hours of cooling. MRI was performed in surviving infants at target 7-10 days of life and was scored by a pediatric neuroradiologist masked to biomarker and clinical data. MEASUREMENTS AND MAIN

resultsSerial biomarker levels were determined in 20 hypoxic ischemic encephalopathy patients. Ubiquitin carboxyl-terminal esterase L1 was higher at initiation and 72 hours of cooling, while glial fibrillary acidic protein was higher at 24 and 72 hours in babies with adverse outcome compared with those with favorable outcome.

conclusionsThis preliminary data support further studies to evaluate ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein as immediate biomarkers of cerebral injury severity in newborns with hypoxic ischemic encephalopathy.

Indexed as

Hypothermia, InducedMagnetic Resonance ImagingBiomarkersBrain InjuriesFemaleGlial Fibrillary Acidic ProteinHumansHypoxia-Ischemia, BrainInfant, NewbornMalePilot ProjectsProspective StudiesROC CurveSeverity of Illness IndexTreatment OutcomeUbiquitin ThiolesteraseBiomarkersGlial Fibrillary Acidic ProteinUbiquitin ThiolesteraseUCHL1 protein, human

Identifiers

PMID23392373
PMCPMC4420174
OpenAlexW2055738785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.